Search Results - "Ceriani, Laura"

The glycocalyx affects the mechanotransductive perception of the topographical microenvironment by Chighizola, Matteo, Dini, Tania, Marcotti, Stefania, D'Urso, Mirko, Piazzoni, Claudio, Borghi, Francesca, Previdi, Anita, Ceriani, Laura, Folliero, Claudia, Stramer, Brian, Lenardi, Cristina, Milani, Paolo, Podestà, Alessandro, Schulte, Carsten

“…Abstract The cell/microenvironment interface is the starting point of integrin-mediated mechanotransduction, but many details of mechanotransductive signal…”
Get full text

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models by Guffanti, Federica, Chilà, Rosaria, Bello, Ezia, Zucchetti, Massimo, Zangarini, Monique, Ceriani, Laura, Ferrari, Mariella, Lupi, Monica, Jacquet-Bescond, Anne, Burbridge, Mike F, Pierrat, Marie-Jeanne, Damia, Giovanna

“…Abstract The fibroblast growth factor receptor (FGFR) pathway has been implicated both as an escape mechanism from anti-angiogenic therapy and as a driver…”
Get full text

MO502: Use of Lithium, Valproate and the Risk of Acute or Chronic Kidney Disease: An Observational Study From Routine Care Data by Bosi, Alessandro, Laura, Ceriani, Fu, Edouard, Runesson, Björn, M. Clase, Catherine, Chang, Zheng, Landen, Mikael, Elinder, Carl-Gustaf, Jesus Carrero, Juan, Bellocco, Rino

“…Abstract BACKGROUND AND AIMS Lithium is an established treatment for bipolar disorder and treatment-resistant depression. Despite awareness of potential kidney…”
Get full text

Quality of laboratory biomarker monitoring during treatment with lithium in patients with bipolar disorder by Bosi, Alessandro, Ceriani, Laura, Elinder, Carl-Gustaf, Bellocco, Rino, Clase, Catherine M, Landen, Mikael, Carrero, Juan-Jesus, Runesson, Björn

“…Clinical guidelines recommend monitoring of creatinine and lithium throughout treatment with lithium. We here assessed the extent to which this occurs in…”
Get full text

Quantification of trabectedin in human plasma: Validation of a high-performance liquid chromatography–mass spectrometry method and its application in a clinical pharmacokinetic study by Zangarini, Monique, Ceriani, Laura, Sala, Federica, Marangon, Elena, Bagnati, Renzo, D’Incalci, Maurizio, Grosso, Federica, Zucchetti, Massimo

“…•Trabectedin was determined in human plasma by LC–MS/MS.•The method was developed and validated in a small amount of human plasma.•Extraction procedure based…”
Get full text

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models12 by Guffanti, Federica, Chilà, Rosaria, Bello, Ezia, Zucchetti, Massimo, Zangarini, Monique, Ceriani, Laura, Ferrari, Mariella, Lupi, Monica, Jacquet-Bescond, Anne, Burbridge, Mike F., Pierrat, Marie-Jeanne, Damia, Giovanna

“…The fibroblast growth factor receptor (FGFR) pathway has been implicated both as an escape mechanism from anti-angiogenic therapy and as a driver oncogene in…”
Get full text

HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies by Zangarini, Monique, Ceriani, Laura, Bello, Ezia, Damia, Giovanna, Cereda, Roberta, Camboni, Maria Gabriella, Zucchetti, Massimo

“…We developed and validated a high‐performance liquid chromatography–tandem mass spectrometry analytical method to measure E‐3810, a novel dual inhibitor of…”
Get full text

HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies: HPLC-MS/MS analysis of E-3810 in human tumor by Zangarini, Monique, Ceriani, Laura, Bello, Ezia, Damia, Giovanna, Cereda, Roberta, Camboni, Maria Gabriella, Zucchetti, Massimo

Get full text

Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden by Bosi, Alessandro, Clase, Catherine M, Ceriani, Laura, Sjölander, Arvid, Fu, Edouard L, Runesson, Björn, Chang, Zheng, Landén, Mikael, Bellocco, Rino, Elinder, Carl-Gustaf, Carrero, Juan Jesus

“…Among patients with bipolar disorder, discordant findings have been published on the nephrotoxic effects of lithium therapy. To quantify absolute and relative…”
Get full text

Abstract 2670: Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models by Bello, Ezia, Chilà, Rosaria, Guffanti, Federica, Zangarini, Monique, Ceriani, Laura, Zucchetti, Massimo, Chaudi, Saba, Pierrat, Marie-Jeanne, Jacquet-Bescond, Anne, Damia, Giovanna L.M.

“…Abstract Lucitanib (S80881, formerly E-3810) is a novel tyrosine kinase inhibitor that selectively inhibits vascular endothelial growth factor (VEGF) receptors…”
Get full text

HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model by Ceriani, Laura, Ferrari, Mariella, Zangarini, Monique, Licandro, Simonetta Andrea, Bello, Ezia, Frapolli, Roberta, Falcetta, Francesca, D'Incalci, Maurizio, Libener, Roberta, Grosso, Federica, Aviles, Pablo, Zucchetti, Massimo

“…Trabectedin is an anticancer agent registered for the second-line treatment of soft tissue sarcoma and ovarian cancer. No preclinical data are available on its…”
Get full text